Cortexyme Inc.

💊 Neuropharmaceuticals· 📍 San Francisco, CA, USA

Overview

Cortexyme develops small-molecule therapeutics targeting bacterial pathogens linked to Alzheimer's disease neuroinflammation and neurodegeneration.

Neuros Life Sciences

San Diego, CA

Neuralstem Inc.

Germantown, MD, USA

Neurogenix Therapeutics

Basel, Switzerland

Acadia Pharmaceuticals

San Diego, USA

Acer Therapeutics

Newton, MA, USA

Praxis Precision Medicine

Cambridge, MA, USA

BlueWind Medical's Revi Extend Wins FDA Clearance, Extending Implant Life to 15 Years

2026-08-06 · Product

Neurofeedback Systems Market Eyes $2.95 Billion Valuation by 2035 as Clinical and Consumer Demand Converge

2026-08-05 · Industry

Smaller Neuromodulation Devices Are Reshaping the Competitive Landscape for TMS Providers

2026-08-04 · Industry

NIH-Backed Brain-Computer Device Restores Speech in Paralyzed Patient

2026-08-03 · Research

Claim this listing to add your logo, full description, team, and products. Premium listings get featured placement.

Advertise

Newsletter sponsorships, featured listings, and sponsored articles.